D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 69 Citations 16,039 205 World Ranking 1643 National Ranking 817

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • Immune system

The scientist’s investigation covers issues in Immunology, Cancer research, Lymphokine-activated killer cell, Cell biology and Interferon. Her biological study spans a wide range of topics, including Haematopoiesis and Peripheral blood mononuclear cell. Her Natural killer T cell research extends to Lymphokine-activated killer cell, which is thematically connected.

Her Cell biology research incorporates themes from Perforin, Natural killer cell and Janus kinase 3. Her Interferon research incorporates elements of T lymphocyte and Interferon gamma. Her research integrates issues of Neoplasm and Serology, Antibody in her study of Virology.

Her most cited work include:

  • Natural Killer Cells: Characteristics and Regulation of Activity (526 citations)
  • Natural Killer Cells: Characteristics and Regulation of Activity (526 citations)
  • Natural Killer Cells: Characteristics and Regulation of Activity (526 citations)

What are the main themes of her work throughout her whole career to date?

Julie Y. Djeu focuses on Immunology, Molecular biology, Cancer research, Lymphokine-activated killer cell and Cytokine. Immunology and Cytotoxic T cell are frequently intertwined in her study. The various areas that Julie Y. Djeu examines in her Cancer research study include Apoptosis, Protein kinase B, Signal transduction, Prostate cancer and Immunotherapy.

Her Lymphokine-activated killer cell study combines topics in areas such as Natural killer T cell, Natural killer cell, Cell biology and Monocyte. Her Cytokine study combines topics from a wide range of disciplines, such as Tumor necrosis factor alpha, Granulocyte and Microbiology, Candida albicans. As part of the same scientific family, she usually focuses on Virology, concentrating on Serology and intersecting with Neoplasm.

She most often published in these fields:

  • Immunology (48.15%)
  • Molecular biology (22.69%)
  • Cancer research (22.22%)

What were the highlights of her more recent work (between 2006-2020)?

  • Cancer research (22.22%)
  • Immunology (48.15%)
  • Immune system (14.35%)

In recent papers she was focusing on the following fields of study:

Her primary areas of investigation include Cancer research, Immunology, Immune system, Cancer and Cell biology. Her Cancer research research is multidisciplinary, incorporating perspectives in Cell culture, Apoptosis, T cell, Prostate cancer and Radiation therapy. Her Immunology research includes themes of Haematopoiesis, Internal medicine and Myeloid-derived Suppressor Cell.

Her Cell biology research integrates issues from Receptor, Immune receptor, Large Granular Lymphocytes and Lymphokine-activated killer cell. Her work deals with themes such as Natural killer T cell and Cytotoxicity, which intersect with Lymphokine-activated killer cell. Her study looks at the intersection of Lymphocyte and topics like Cytotoxic T cell with Molecular biology and Calcium flux.

Between 2006 and 2020, her most popular works were:

  • A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers (331 citations)
  • Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer (251 citations)
  • Induction of myelodysplasia by myeloid-derived suppressor cells. (174 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

Her primary scientific interests are in Immunology, Cancer research, Clusterin, Leukemia and Bone marrow. She combines subjects such as Internal medicine, Stem cell and Myeloid-derived Suppressor Cell with her study of Immunology. Her study in Cancer research is interdisciplinary in nature, drawing from both Cancer, Cytoprotection, Apoptosis, Protein kinase B and Transfection.

Her studies deal with areas such as Translational research, Protein stabilization, Computational biology and Bioinformatics as well as Clusterin. Her Leukemia study integrates concerns from other disciplines, such as Immunosurveillance, Myeloid, Receptor, NKG2D and Myeloid leukemia. Her research in Bone marrow intersects with topics in Phosphatase, Ubiquitin, Mdm2 and Hyperphosphorylation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Natural Killer Cells: Characteristics and Regulation of Activity

Ronald B. Herberman;Ronald B. Herberman;Ronald B. Herberman;Julie Y. Djeu;Julie Y. Djeu;Julie Y. Djeu;H. David Kay;H. David Kay;H. David Kay;John R. Ortaldo;John R. Ortaldo;John R. Ortaldo.
Immunological Reviews (1979)

687 Citations

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

Elizabeth Ann Grimm;Keith M. Ramsey;Amitabha Mazumder;Debra J. Wilson.
Journal of Experimental Medicine (1983)

673 Citations

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

A H Rook;H Masur;H C Lane;W Frederick.
Journal of Clinical Investigation (1983)

502 Citations

A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers

Krithika N. Kodumudi;Karrune Woan;Danielle L. Gilvary;Eva Sahakian.
Clinical Cancer Research (2010)

491 Citations

Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells.

Kun Jiang;Bin Zhong;Danielle L. Gilvary;Brian C. Corliss.
Nature Immunology (2000)

479 Citations

Circulating activated suppressor T lymphocytes in aplastic anemia.

Nicholas C. Zoumbos;Pedro Gascón;Julie Y. Djeu;Stephen R. Trost.
The New England Journal of Medicine (1985)

476 Citations

Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

Nicholas C. Zoumbos;Pedro Gascon;Julie Y. Djeu;Neal S. Young.
Proceedings of the National Academy of Sciences of the United States of America (1985)

448 Citations

Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor.

J Y Djeu;D K Blanchard;D Halkias;H Friedman.
Journal of Immunology (1986)

411 Citations

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

Kong W;He L;Richards Ej;Challa S.
Oncogene (2014)

409 Citations

Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.

James Turkson;Tammy Bowman;Jalila Adnane;Yi Zhang.
Molecular and Cellular Biology (1999)

338 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Julie Y. Djeu

Alan F. List

Alan F. List

Precision BioSciences

Publications: 60

Thomas P. Loughran

Thomas P. Loughran

University of Virginia

Publications: 54

Gary W. Litman

Gary W. Litman

University of South Florida

Publications: 49

Neal S. Young

Neal S. Young

National Institutes of Health

Publications: 45

Jaroslaw P. Maciejewski

Jaroslaw P. Maciejewski

Cleveland Clinic

Publications: 38

Ronald B. Herberman

Ronald B. Herberman

University of Pittsburgh

Publications: 34

Thomas W. Klein

Thomas W. Klein

University of South Florida

Publications: 34

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 33

Herman Friedman

Herman Friedman

University of South Florida

Publications: 33

Richard Jove

Richard Jove

Nova Southeastern University

Publications: 30

John R. Ortaldo

John R. Ortaldo

National Institutes of Health

Publications: 27

Francesco Bistoni

Francesco Bistoni

University of Perugia

Publications: 27

Angela Santoni

Angela Santoni

Sapienza University of Rome

Publications: 25

Mihai G. Netea

Mihai G. Netea

Radboud University Nijmegen

Publications: 24

Anthony S. Fauci

Anthony S. Fauci

National Institute of Allergy and Infectious Diseases

Publications: 22

Said M. Sebti

Said M. Sebti

University of South Florida

Publications: 21

Trending Scientists

Richard N. Taylor

Richard N. Taylor

University of California, Irvine

Arnold Reusken

Arnold Reusken

RWTH Aachen University

Sui-Dong Wang

Sui-Dong Wang

Soochow University

Nathan Kleeorin

Nathan Kleeorin

Ben-Gurion University of the Negev

Roger Ghanem

Roger Ghanem

University of Southern California

Johan Lugtenburg

Johan Lugtenburg

Leiden University

Willem H. van Zyl

Willem H. van Zyl

Stellenbosch University

Shrikant Mane

Shrikant Mane

Yale University

Mathias Lichterfeld

Mathias Lichterfeld

Brigham and Women's Hospital

Ryszard Laskowski

Ryszard Laskowski

Jagiellonian University

Bryan G. Mark

Bryan G. Mark

The Ohio State University

Jonathan D. Powell

Jonathan D. Powell

Johns Hopkins University School of Medicine

Masaki Kitajima

Masaki Kitajima

Keio University

Terence A. Shimp

Terence A. Shimp

University of South Carolina

Richard H. McAdams

Richard H. McAdams

University of Chicago

Something went wrong. Please try again later.